Low muscle mass at treatment initiation is associated with early loss of response to anti-TNF therapy for Inflammatory Bowel Disease

被引：0
|
作者：
Holt, D. [1 ,2 ,3 ]
Varma, P. [1 ]
Strauss, B. [3 ]
Moore, G. [1 ,3 ]
机构：
[1] Monash Univ, Gastroenterol & Hepatol Unit, Melbourne, Vic 3004, Australia
[2] Monash Univ, Clin Nutr & Metab Unit, Melbourne, Vic 3004, Australia
[3] Monash Univ, Sch Clin Sci, Dept Med, Melbourne, Vic 3004, Australia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2015年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：131 / 131
页数：1
相关论文
共 50 条
  • [1] Low muscle mass at initiation of anti-TNF therapy for inflammatory bowel disease is associated with early treatment failure: a retrospective analysis
    Holt, D. Q.
    Varma, P.
    Strauss, B. J. G.
    Rajadurai, A. S.
    Moore, G. T.
    EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2017, 71 (06) : 773 - 777
  • [2] Low muscle mass at initiation of anti-TNF therapy for inflammatory bowel disease is associated with early treatment failure: a retrospective analysis
    D Q Holt
    P Varma
    B J G Strauss
    A S Rajadurai
    G T Moore
    European Journal of Clinical Nutrition, 2017, 71 : 773 - 777
  • [3] IMMUNOMODULATOR WITHDRAWAL FROM ANTI-TNF THERAPY IS NOT ASSOCIATED WITH LOSS OF RESPONSE IN INFLAMMATORY BOWEL DISEASE
    Mahmoud, Remi
    Schultheiss, Johannes P.
    Louwers, Jonas M.
    van der Kaaij, Michiel T.
    van Hellemondt, Boris P.
    Mahmmod, Nofel
    van Boeckel, Petra G.
    Jharap, Bindia
    Fidder, Herma H.
    Oldenburg, Bas
    GASTROENTEROLOGY, 2022, 162 (07) : S184 - S184
  • [4] Immunomodulator Withdrawal From Anti-TNF Therapy Is Not Associated With Loss of Response in Inflammatory Bowel Disease
    Mahmoud, Remi
    Schultheiss, Hans-Paul
    Louwers, Jonas
    van der Kaaij, Michiel
    van Hellemondt, Boris
    Mahmmod, Nofel
    van Boeckel, Petra
    Jharap, Bindia
    Fidder, Herma
    Oldenburg, Bas
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (11) : 2577 - +
  • [5] Loss of response to anti-TNF in inflammatory bowel disease in a Portuguese centre
    Sousa, M.
    Silva, A. P.
    Rodrigues, A.
    Rodrigues, J.
    Silva, J.
    Gomes, C.
    Proenca, L.
    Carvalho, J.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S313 - S314
  • [6] Anti-TNF Treatment in Inflammatory Bowel Disease
    Yapali, Suna
    Hamzaoglu, Hulya Over
    ANNALS OF GASTROENTEROLOGY, 2007, 20 (01): : 48 - 53
  • [7] Loss of response to anti-TNFα agents depends on treatment duration in patients with inflammatory bowel disease
    Schultheiss, Johannes P. D.
    Mahmoud, Remi
    Louwers, Jonas M.
    van der Kaaij, Michiel T.
    van Hellemondt, Boris P.
    van Boeckel, Petra G.
    Mahmmod, Nofel
    Jharap, Bindia
    Fidder, Herma H.
    Oldenburg, Bas
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (10) : 1298 - 1308
  • [8] Longitudinal Outcomes of Anti-TNF Therapy in the Treatment of Inflammatory Bowel Disease
    Roney, Andrew R.
    Orr, Dupre
    Barghi, Armeen
    Cusumano, Vivy
    Limketkai, Berkeley
    Sauk, Jenny
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S768 - S769
  • [9] Outcomes post methotrexate salvage therapy after anti-TNF loss of response in inflammatory bowel disease
    Cunningham, G.
    Kodikara, C.
    Varma, P.
    Moore, G. T.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 131 - 131
  • [10] Optimizing anti-TNF treatment in inflammatory bowel disease
    Rutgeerts, P
    Van Assche, G
    Vermeire, S
    GASTROENTEROLOGY, 2004, 126 (06) : 1593 - 1610
12345